Iqbal, N., Allen, E., & Öhman, P. (2014). Long-term safety and tolerability of saxagliptin add-on therapy in older patients (aged ≥65 years) with type 2 diabetes. Dove Medical Press.
Chicago Style CitationIqbal, Nayyar, Elsie Allen, and Peter Öhman. Long-term Safety and Tolerability of Saxagliptin Add-on Therapy in Older Patients (aged �65 Years) With Type 2 Diabetes. Dove Medical Press, 2014.
MLA CitationIqbal, Nayyar, Elsie Allen, and Peter Öhman. Long-term Safety and Tolerability of Saxagliptin Add-on Therapy in Older Patients (aged �65 Years) With Type 2 Diabetes. Dove Medical Press, 2014.
Warning: These citations may not always be 100% accurate.